info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Breast Biopsy Companies

Breast biopsies are medical procedures that involve the removal of tissue samples from the breast for examination, typically to determine the presence of cancer or other abnormalities. Breast biopsy companies specialize in providing products and technologies for the diagnosis and assessment of breast abnormalities.

Breast Biopsy Companies

 


Latest Breast Biopsy Companies Updates


Hologic,Introduced their new Symphony® Guided Biopsy System featuring enhanced imaging capabilities and improved needle placement accuracy.Collaborated with leading researchers on clinical trials evaluating the efficacy of their VABio™ Breast Biopsy System for detecting breast cancer.


Boston Scientific Corporation Received FDA approval for their Eclipse™ Tissue Sampling System, a novel minimally invasive needle biopsy device for breast cancer diagnosis.Partnered with healthcare providers to implement advanced biopsy technologies and optimize workflow efficiency in breast cancer diagnosis.


Cantel Medical Corporation Launched their TruCore® PRO Biopsy System with innovative targeting technology and needle design for improved lesion access and sample acquisition.Focused on expanding their global presence and market share in the breast biopsy market.


Exact Sciences Corporation Announced positive results from Phase 3 clinical trials demonstrating the effectiveness of their Oncotype DX Recurrence Score® test in guiding treatment decisions for early-stage breast cancer patients after core needle biopsy.Partnered with laboratories and medical centers to increase access to their personalized molecular diagnostics for breast cancer risk assessment.


List of Breast Biopsy Key companies in the market




  • Medical Technologies LLC,




  • STERYLAB S.r.l.,




  • ARGON MEDICAL,




  • Danaher,




  • Cianna Medical,




  • United Medical Systems Inc.,




  • Stryker,




  • Hologic Inc.,




  • Devicor Medical Products Inc.,




  • F. Hoffmann-La Roche Ltd.,




  • OncoCyte Corporation




Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.